ACRV - Financial Reports List - Acrivon Therapeutics, Inc. Common Stock - IntrinsicAlpha

Acrivon Therapeutics, Inc. Common Stock ACRV

Healthcare - Biotechnology - NASDAQ - US

$ 1.91

5.52 %

$ 59.9 M

Market Cap

-0.8

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-18.59%	-18.53%
Annual Report	FY	10-K	2024-12-31	0.00%	-33.40%	-32.66%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-55.13%	-55.79%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-35.10%	-38.13%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-48.27%	-22.75%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-143.30%	-111.69%
Annual Report	FY	10-K	2023-12-31	0.00%	-103.48%	-105.89%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-64.00%	-68.53%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-143.46%	-161.94%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-53.83%	-99.57%

1